- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06458660
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence (LPP Plus)
LinkPositively+ An Enhanced Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jamila K Stockman, PhD, MPH
- Phone Number: (858) 822-4652
- Email: jstockman@health.ucsd.edu
Study Contact Backup
- Name: Theodore H Noel, BS
- Phone Number: 320 405) 733-0771
- Email: tnoel@guidingright.org
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73111
- Recruiting
- Guiding Right, Inc.
-
Contact:
- Theodore H Noel, BS
- Phone Number: 320 405-733-0771
- Email: tnoel@guidingright.org
-
Oklahoma City, Oklahoma, United States, 73112
- Recruiting
- New Hope Wellness Center
-
Contact:
- Miya Lewis, BS
- Phone Number: 405-730-0771
- Email: mlewis@nhwellnesscenter.org
-
Tulsa, Oklahoma, United States, 74135
- Recruiting
- Guiding Right, Inc.
-
Contact:
- Michael Merryman
- Phone Number: 918-986-8400
- Email: mmerryman@guidingright.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: a) aged 18 years or older, b) cisgender or transgender woman, c) as Black or African American racial/ethnic identity, d) Living with HIV/AIDS, e) able to read, speak, and understand English, e) ever-experienced physical, sexual, and/or psychological abuse by a current or former partner of non-partner, and f) owner of a smartphone with internet browsing capabilities.
-
Exclusion Criteria: a) Unwillingness to participate in the study, b) cognitive impairment that would limit participation with study procedures, c) Male Gender, d) HIV negative serostats
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Arm: LinkPositively
Women assigned to the LinkPositively arm will have access to all four components of the LinkPositively app.
Women will be scheduled for a session with staff to inform them of their assigned virtual Peer Navigator (PN).
Staff will train participants on how to download the app, explain the five components, using each component, and contacting their PN.
Within the first week after, virtual PNs will complete a one-on-one, in-person or phone intake session with the participant, based on the participant's preference.
During this intake session, the PN will conduct a participant needs assessment to connect her to HIV medical care via local health clinics and identify other areas of need, services of need, and assisted referrals (domestic violence services, mental health care, substance abuse treatment, housing and legal support, etc.).
PNs will provide trauma-informed emotional and informational support, including guidance on accessing information about referred services.
|
LinkPositively is a culturally tailored, trauma-informed smartphone app for Black women living with HIV/AIDS affected by interpersonal violence.
Core components of LinkPositively include: a) Virtual Peer Navigation that includes phone and text check-ins and 4 weekly one-on-one video sessions to build skills to cope with barriers and navigate care; b) Social Networking platform to receive peer support; c) Educational and Self-care database with healthy living and self-care tips; d) GPS-enabled Resource Locator for HIV care and ancillary support service agencies; and e) ART self-monitoring and reminder system.
|
|
Experimental: Intervention Arm: LinkPositively+
Women assigned to the LPP+ arm will receive all components of the LP arm plus access to mindfulness videos via the app, in addition to participating in a virtual 6-session weekly, PN led mindfulness meditation enhanced intervention.
The sessions will be delivered in real time, by PNs and will involve 1 on 1 discussions on a) the principles and health benefits of mindfulness meditation, b) lived experiences of women living with HIV and intersectional identities of being Black, and doubling identifying as women, c) experiencing trauma in personal relationships, d) ethnic pride, e) sex/gender pride, and f) positive self-affirmations.
Sessions will be conducted online, in-app, and include culturally congruent video clips, role playing, and skills building activities that enhance self-pride and coping during stressful situations.
|
During the 6-week intervention period, participants will receive reminder SMS text messages at a time selected by the participant at 48 and 24-hrs before each scheduled study visit.
Within 24 hours after every session, participants will receive an SMS text reminder to complete a session satisfaction survey.
If the satisfaction surveys are not completed within 48 hours after each session, participants will receive an additional SMS text message once per day for three consecutive days after each planned study visit.
Twenty-four hours before each scheduled study visit after study visit number 1, participants will an SMS text requiring a one-character response (1= yes, 2=no), asking if participants practiced any mindfulness meditation techniques since the last session.
Participants who have not interacted with the app during the previous week will receive an accountability call to assess barriers to participation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Preliminary effect of LPP+ to improve HIV care outcomes
Time Frame: 3- and 6-month Post Baseline
|
The study aims to examine the preliminary effect of LPP+; mindfulness meditation plus PN plus LP app (e.g., social networking platform, education and self-care tips, resource locator, and ART self-monitoring and reminders) to improve HIV care outcomes including improved retention in HIV care, ART adherence, and viral suppression using empirical hair sample analysis (ART adherence) and passive electronic health medical review (viral suppression).
|
3- and 6-month Post Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- IN-US-985-7186
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on LP
-
Shanxi Kangbao Biological Product Co., Ltd.Institute of Pathogen Biology, Beijing, ChinaRecruiting
-
Longbio PharmaNot yet recruitingChronic Rhinosinusitis With Nasal Polyps (CRSwNP)China
-
Longbio PharmaCompletedMyelodysplastic Syndrome (MDS)China
-
Longbio PharmaCompletedSeasonal Allergic RhinitisChina
-
Abbott Medical DevicesTerminatedAtrial Fibrillation | Coronary Arteriosclerosis | Coronary Artery Bypass Graft SurgeryCanada, United Kingdom, Netherlands, Norway, Finland, Germany
-
Centre Hospitalier Universitaire de NiceCompletedHematological MalignanciesFrance
-
Lipella Pharmaceuticals, Inc.William Beaumont HospitalsCompletedInterstitial CystitisUnited States
-
Longbio PharmaCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)China
-
Longbio PharmaCompletedChronic Spontaneous UrticariaChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Newave Pharmaceutical Inc; Atrium Health Wake...Not yet recruitingPhiladelphia Positive Acute Lymphoblastic LeukemiaUnited States